MDR in Candida: The Real Storm
摘要
Systemic Candida infection is reported as a major cause of infection and death in nosocomial and critically ill patients. The antifungal arsenal belongs to the limited class and is available to treat resistance in Candida that enhances the severity of infection and cost of treatment. Even multidrug resistance (MDR) is rarely reported but the frequency of MDR is increasing day by day. This book chapter tries to focus on its pathogenesis, morphogenesis, available antifungals, and drug resistance.